These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 1495020)

  • 1. Probing the molecular basis of resistance to pyrimethamine by site-directed mutagenesis.
    Wagner CR; Benkovic SJ
    J Med Chem; 1992 Jul; 35(15):2912-5. PubMed ID: 1495020
    [No Abstract]   [Full Text] [Related]  

  • 2. Dihydrofolate reductase from pyrimethamine-resistant Plasmodium berghei.
    Ferone R
    J Biol Chem; 1970 Feb; 245(4):850-4. PubMed ID: 5418106
    [No Abstract]   [Full Text] [Related]  

  • 3. Plasmodium berghei dihydrofolate reductase. Isolation, properties, and inhibition by antifolates.
    Ferone R; Burchall JJ; Hitchings GH
    Mol Pharmacol; 1969 Jan; 5(1):49-59. PubMed ID: 4392112
    [No Abstract]   [Full Text] [Related]  

  • 4. Novel alleles of Plasmodium falciparum dhfr that confer resistance to chlorcycloguanil.
    Hunt SY; Rezvani BB; Sibley CH
    Mol Biochem Parasitol; 2005 Jan; 139(1):25-32. PubMed ID: 15610816
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The dihydrofolate reductase domain of rodent malarias: point mutations and pyrimethamine resistance.
    Cheng Q; Saul A
    Mol Biochem Parasitol; 1994 Jun; 65(2):361-3. PubMed ID: 7969277
    [No Abstract]   [Full Text] [Related]  

  • 6. Addressing cumulative selection.
    Behe MJ
    Science; 2007 Oct; 318(5848):196; author reply 196. PubMed ID: 17932270
    [No Abstract]   [Full Text] [Related]  

  • 7. [A new cytochemical method for the study of the tetrahydrofolatereductase activity in Plasmodium berghei: analysis of the effect of specific inhibitors].
    Gerzeli G; Polver Pde P
    Riv Parassitol; 1969 Mar; 30(1):19-26. PubMed ID: 5405877
    [No Abstract]   [Full Text] [Related]  

  • 8. Virulence and drug resistance in malaria parasites.
    Stein WD; Sanchez CP; Lanzer M
    Trends Parasitol; 2009 Oct; 25(10):441-3. PubMed ID: 19734096
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Action of pyrimethamine and related drugs against Plasmodium knowlesi in vitr.
    Gutteridge WE; Trigg PI
    Parasitology; 1971 Jun; 62(3):431-44. PubMed ID: 4997058
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular dynamics of interactions between rigid and flexible antifolates and dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium falciparum.
    Mokmak W; Chunsrivirot S; Hannongbua S; Yuthavong Y; Tongsima S; Kamchonwongpaisan S
    Chem Biol Drug Des; 2014 Oct; 84(4):450-61. PubMed ID: 24716467
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of bacterial surrogates as a tool to explore antimalarial drug interaction: Synergism between inhibitors of malarial dihydrofolate reductase and dihydropteroate synthase.
    Talawanich Y; Kamchonwongpaisan S; Sirawaraporn W; Yuthavong Y
    Acta Trop; 2015 Sep; 149():64-9. PubMed ID: 25997881
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Kinetic and molecular properties of dihydrofolate reductase from pyrimethamine-sensitive and pyrimethamine-resistant Plasmodium chabaudi.
    Sirawaraporn W; Yuthavong Y
    Mol Biochem Parasitol; 1984 Mar; 10(3):355-67. PubMed ID: 6727925
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular epidemiology of malaria in Yaounde, Cameroon. VI. Sequence variations in the Plasmodium falciparum dihydrofolate reductase-thymidylate synthase gene and in vitro resistance to pyrimethamine and cycloguanil.
    Basco LK; Ringwald P
    Am J Trop Med Hyg; 2000 Feb; 62(2):271-6. PubMed ID: 10813484
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mutations associated with sulfadoxine-pyrimethamine and chlorproguanil resistance in Plasmodium falciparum isolates from Blantyre, Malawi.
    Alker AP; Mwapasa V; Purfield A; Rogerson SJ; Molyneux ME; Kamwendo DD; Tadesse E; Chaluluka E; Meshnick SR
    Antimicrob Agents Chemother; 2005 Sep; 49(9):3919-21. PubMed ID: 16127071
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Plasmodium falciparum: direct cloning and expression of pyrimethamine-sensitive and pyrimethamine-resistant dihydrofolate reductase domains.
    Hekmat-Nejad M; Lee PC; Rathod PK
    Exp Parasitol; 1997 Mar; 85(3):303-5. PubMed ID: 9085928
    [No Abstract]   [Full Text] [Related]  

  • 16. Heterologous expression of active thymidylate synthase-dihydrofolate reductase from Plasmodium falciparum.
    Sirawaraporn W; Sirawaraporn R; Cowman AF; Yuthavong Y; Santi DV
    Biochemistry; 1990 Dec; 29(48):10779-85. PubMed ID: 2176883
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro generation of novel pyrimethamine resistance mutations in the Toxoplasma gondii dihydrofolate reductase.
    Reynolds MG; Oh J; Roos DS
    Antimicrob Agents Chemother; 2001 Apr; 45(4):1271-7. PubMed ID: 11257045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In silico screening against wild-type and mutant Plasmodium falciparum dihydrofolate reductase.
    Fogel GB; Cheung M; Pittman E; Hecht D
    J Mol Graph Model; 2008 Apr; 26(7):1145-52. PubMed ID: 18037315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Conflicting requirements of Plasmodium falciparum dihydrofolate reductase mutations conferring resistance to pyrimethamine-WR99210 combination.
    Japrung D; Leartsakulpanich U; Chusacultanachai S; Yuthavong Y
    Antimicrob Agents Chemother; 2007 Dec; 51(12):4356-60. PubMed ID: 17875995
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular basis of differential resistance to cycloguanil and pyrimethamine in Plasmodium falciparum malaria.
    Peterson DS; Milhous WK; Wellems TE
    Proc Natl Acad Sci U S A; 1990 Apr; 87(8):3018-22. PubMed ID: 2183222
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.